ClinConnect ClinConnect Logo
Search / Trial NCT06382077

Chronic Post Surgical Pain-Cardiac

Launched by ONDOKUZ MAYIS UNIVERSITY · Apr 19, 2024

Trial Information

Current as of June 27, 2025

Recruiting

Keywords

Cardiac Anesthesia Chronic Post Surgical Pain Nerve Blocks

ClinConnect Summary

The Chronic Post Surgical Pain-Cardiac trial is a study that looks at how common chronic pain is three months after heart surgery, such as coronary artery bypass grafting or other open-heart procedures. Researchers want to understand the factors that might influence this pain, which can be an important issue for many patients recovering from surgery.

To participate, patients need to be between 18 and 80 years old and scheduled for their first heart surgery that requires a certain type of chest opening called a median sternotomy. The study is open to all genders, and participants will need to sign a consent form agreeing to take part. Those who have had certain types of surgeries before, have severe health issues, or cannot communicate effectively will not be eligible. If you join the study, you'll be asked questions about your pain and recovery during follow-up calls after your surgery. This research aims to help improve care for future heart surgery patients.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • patients will be undergoing a first-time cardiac surgery involving a median sternotomy, including coronary artery bypass grafting (CABG) and all open-heart procedures, such as valvular repairs/replacement.
  • patients between the ages of 18-80 years
  • American Society of Anesthesiologists (ASA) Physical Status score of II-III
  • patients will also sign the written informed consent form
  • Exclusion Criteria:
  • patients scheduled for minimally invasive cardiac surgery,
  • patients with BMI\>40,
  • patients who undergone thoracotomy,
  • patients with alcohol and drug addiction,
  • patients with severe dysfunction in a significant organ (e.g., presence of severe hepatic and renal disease),
  • patients who undergone emergency and redo surgeries,
  • patients who cannot be extubated within the first 8 hours postoperatively,
  • patients have a severe psychiatric diseases such as psychosis or dementia that restrict cooperation with the patient (patients who cannot evaluate verbal numerical pain scales),
  • patients who are pregnant and breastfeeding,
  • patients who cannot be reached by phone during the postoperative follow-up periods
  • patients who cannot communicate in the native language.

About Ondokuz Mayıs University

Ondokuz Mayıs University is a prestigious academic institution located in Turkey, renowned for its commitment to advancing medical research and education. As a clinical trial sponsor, the university leverages its cutting-edge facilities and a multidisciplinary team of experts to conduct innovative studies that aim to enhance patient care and contribute to scientific knowledge. With a focus on ethical standards and rigorous methodologies, Ondokuz Mayıs University is dedicated to fostering collaborations that drive breakthroughs in healthcare, ultimately improving treatment outcomes and patient well-being.

Locations

Istanbul, , Turkey

Bursa, , Turkey

Ankara, , Turkey

Istanbul, , Turkey

Kocaeli, , Turkey

Trabzon, , Turkey

Istanbul, , Turkey

Erzurum, , Turkey

Antalya, , Turkey

Mersin, , Turkey

Ankara, , Turkey

Samsun, Atakum, Turkey

Bursa, , Turkey

Samsun, , Turkey

Adana, , Turkey

Samsun, , Turkey

çorum, , Turkey

Ankara, , Turkey

Antalya, , Turkey

Bursa, , Turkey

Istanbul, , Turkey

Istanbul, , Turkey

Istanbul, , Turkey

İ̇stanbul, , Turkey

Muğla, , Turkey

Trabzon, , Turkey

çanakkale, , Turkey

şanlıurfa, , Turkey

Adıyaman, , Turkey

Denizli, , Turkey

Düzce, , Turkey

Gaziantep, , Turkey

Isparta, , Turkey

Istanbul, , Turkey

Kocaeli, , Turkey

Rize, , Turkey

Patients applied

0 patients applied

Trial Officials

Burhan DOST, Assoc.Prof

Study Director

Ondokuz Mayıs University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported